- Home
- SRZN vs DOMH Comparison
SRZN vs DOMH Comparison
Compare SRZN & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- DOMH
- Stock Information
- Founded
- SRZN 2015
- DOMH 1967
- Country
- SRZN United States
- DOMH United States
- Employees
- SRZN N/A
- DOMH N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- SRZN Health Care
- DOMH Health Care
- Exchange
- SRZN Nasdaq
- DOMH Nasdaq
- Market Cap
- SRZN 97.3M
- DOMH 94.0M
- IPO Year
- SRZN N/A
- DOMH N/A
- Fundamental
- Price
- SRZN $13.73
- DOMH $5.70
- Analyst Decision
- SRZN Strong Buy
- DOMH
- Analyst Count
- SRZN 2
- DOMH 0
- Target Price
- SRZN $38.50
- DOMH N/A
- AVG Volume (30 Days)
- SRZN 22.2K
- DOMH 257.8K
- Earning Date
- SRZN 11-07-2025
- DOMH 11-12-2025
- Dividend Yield
- SRZN N/A
- DOMH 9.41%
- EPS Growth
- SRZN N/A
- DOMH N/A
- EPS
- SRZN N/A
- DOMH N/A
- Revenue
- SRZN $12,621,000.00
- DOMH $52,811,000.00
- Revenue This Year
- SRZN N/A
- DOMH N/A
- Revenue Next Year
- SRZN N/A
- DOMH N/A
- P/E Ratio
- SRZN N/A
- DOMH N/A
- Revenue Growth
- SRZN N/A
- DOMH 455.38
- 52 Week Low
- SRZN $5.90
- DOMH $0.83
- 52 Week High
- SRZN $18.17
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- SRZN 59.16
- DOMH 45.09
- Support Level
- SRZN $13.55
- DOMH $5.73
- Resistance Level
- SRZN $13.94
- DOMH $6.21
- Average True Range (ATR)
- SRZN 0.33
- DOMH 0.39
- MACD
- SRZN -0.08
- DOMH -0.03
- Stochastic Oscillator
- SRZN 46.94
- DOMH 32.56
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.